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Introduction: Non-invasive positive pressure ventilation (NIPPV) is an effective
treatment in respiratory failure. Continuous positive pressure (CPAP) may also be
useful in acute hypoxaemic patients. Supplementary oxygen is usually necessary in
both systems. However, the inspired oxygen fraction (FiO2) delivered by a NIV
portable ventilator is unknown. The main objectives of this study were to establish
the maximal FiO2 that could be achieved by these devices and to analyse the FiO2
determinant factors.
Method: Ten healthy volunteers were evaluated using a BiPAP ST30 ventilator
(Respironics, USA) with a single-limb circuit, expiratory port and nasal mask
(Respironics, USA). Oxygen (15 L/min) was administered at two connection points
(proximal and distal). Each volunteer carried out a NIPPV (inspiratory pressure
20 cmH2O [1.95 kPa]—expiratory pressure 8 cmH2O [0.78 kPa]) and a CPAP (10 cmH2O
[0.981 kPa]) session. FiO2 was analysed by a probe located in the mask. Minute
volume (MV) was measured using a pneumotachograph.
Results: Maximal FiO2 was obtained with CPAP and distal oxygen connection point
(67.39+/15.39%). NIPPV achieved higher MV than CPAP. FiO2 was inversely
correlated with MV.
Conclusions: FiO2 obtained while using a NIPPV portable ventilator depends on the
ventilatory assistant mode, the oxygen connection point and the MV reached.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Non-invasive positive pressure ventilation (NIPPV)
is a ventilatory support system that does notElsevier Ltd. All rights reserve
643281.
tpau.es (D. Samolski).require endotracheal access.1 It has proved to be
effective in both acute and chronic ventilatory
failure settings.1–4 Continuous positive pressure
(CPAP), on the other hand, is preferentially used
in obstructive sleep apnoea syndrome patients
(OSAS), but may also be useful in acute hypoxaemic
respiratory failure.5d.
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FiO2 in non-invasive ventilation 1609Although NIPPV use is largely accepted for
hypercarbic respiratory failure treatment, there
are few clinical hypoxemic situations in which
NIPPV could be useful.6–8 During acute and chronic
respiratory failure, oxygen treatment may need to
be added to NIPPV. In portable NIPPV ventilators,
oxygen can be administered through the mask or
through another part of the single-limb circuit,
making it difficult to determine the exact inspired
oxygen fraction (FiO2) administered to the patient.
In addition, the maximum FiO2 (mFiO2) provided by
these devices may be insufficient in some patients
with severe hypoxemia. mFiO2 has been related
with inspiratory (IPAP) and expiratory positive
airway pressure (EPAP) levels, oxygen flow rate,
oxygen connection point in the ventilator system,
tidal volume and locations of FiO2 measurement.
The main objective of this study was to evaluate the
mFiO2 value that could be achieved with a portable
ventilator commonly used in NIPPV. We also aimed to
confirm our hypothesis that the ventilatory mode, the
oxygen connection point and the minute volume (MV)
could play an influential role in the FiO2 achieved.Materials and method
The study was conducted in the pulmonary function
laboratory of our hospital with the participation ofFigure 1 Diagram of the ventil10 healthy volunteers. The project was approved by
the Hospital Ethics Committee.Protocol
Ten healthy volunteers were evaluated. None had a
history of smoking or acute diseases or were taking
prescription drugs.
We used a BiPAP ST 30 ventilator (Respironics
Inc., Murraysville, PA, USA) with a single-limb
circuit, a specific expiratory port (Respironics
Inc., Murraysville, PA, USA) and a nasal mask
(Respironics Inc., Murraysville PA, USA). Two oxygen
connection points were selected. One of these, the
proximal connection point (POCP) was placed at
the exit of the portable ventilator, connecting this
device with the single-limb circuit. The other, the
distal connection point (DOCP) was located in the
nasal mask. Oxygen flow was 15 L/min (Fig. 1).
Using a randomised crossover model, we evalu-
ated the following four modes of ventilation: CPAP
(10 cmH2O [0.981 kPa]) plus POCP, CPAP plus DOCP,
NIPPV (IPAP 20 cmH2O [1.95 kPa]—EPAP 8 cmH2O
[0.78 kPa], spontaneous mode) plus POCP and NIPPV
plus DOCP. Each mode of ventilation was adminis-
tered for 10min with patients in a seated position.
A wash-out period of 5min was used between each
mode of ventilatory support.ator and measuring system.
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A no. 2 Fleisch-type pneumotachograph situated
between the mask and the expiratory port analysed
the MV ventilation. The FiO2 administered by the
ventilator was analysed by a probe located in the
mask and connected to an oxygen analyser OH-11
(Sensor Medics, USA) (Fig. 1). FiO2 analysis was
made continuously. Simultaneously, we measured
airflow in the mask, obtaining a clear difference
between inspiratory and expiratory phases. These
data were digitalised and recorded on a personal
computer with an adequate software program
(Global Lab, Marlboro, MA, USA) that integrates
flow signal and transforms it into volume data. In
this way, we recorded the FiO2 throughout the
respiratory cycle. We analysed only the inspira-
tory FiO2, in 10 consecutive respiratory cycles,
guided by the flow signal. In other words, the
software analysed and quantified the inspiratory
FiO2 ‘‘point by point’’, generating an average of all
the measures corresponding to the inspiratory
phase.Statistical analysis
Data are shown as mean and standard deviation. A
comparative analysis was made between FiO2 and
potentially related variables (ventilation mode and
oxygen connection point) by an analysis of the
variance (ANOVA) of two factors: oxygen connec-
tion point (proximal–distal) and ventilation mode
(CPAP–BiPAP), both of repeated measures. This
analysis was made using the Greenhouse-Geisser
correction test to modify a possible non-sphericity
by means of GLM. The MV and FiO2 relationship was
evaluated using Pearson’s correlation coefficient
and the regression line equation was calculated. All
analyses were performed using the SPSS version
11.5 statistical package.100
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Figure 2 Relationship between FiO2 and venResults
mFiO2 was achieved while using CPAP and the DOCP,
reaching a value of 67.39+/15.39%, followed by
BiPAP with the DOCP (58.76+/11.38%), CPAP with
the POCP (51.09+/9.79%) and, finally, BiPAP with
the POCP (44.26+/6.57%). Comparing the same
oxygen connection point, the FiO2 achieved with
the CPAP mode was greater than BiPAP (Po0:006).
Comparing the same ventilatory mode, the DOCP
also achieved greater FiO2 than the POCP
(Po0:0001) (Fig. 2).
MV was greater with BiPAP with both oxygen
connection points: 24.93+/5.69 L/min with POCP
and 19.05+/5.07 L/min with DOCP, comparing
with 15.78+/4.16 L/min and 9.48+/3.05 L/min
while using CPAP with POCP and DOCP, respectively
(Po0:0001) (Fig. 3).
We found an inverted relationship between MV
generated by the patient and the final FiO2
delivered with the ventilator, allowing us to
calculate its regression line (R2 ¼ 0:4046) and
equation (FiO2 ¼ 76.67–1.215 MV) (Fig. 4).Discussion
According to our hypothesis, this study showed that
the oxygen connection point, the ventilatory mode
and the ventilatory MV play an active role in mFiO2
administered by a portable ventilator.
Using the same oxygen connection point, we
observed that CPAP achieved a higher mFiO2 than
BiPAP. There are two possible explanations for
these findings. Firstly, the use of a single level of
CPAP could cause lower dilution of the oxygen
delivered by the ventilator and consequently
create greater FiO2. Secondly, the greater flow
generated in BiPAP mode would favour the escape
of oxygen through the expiratory port itself,P
P
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FiO2 in non-invasive ventilation 1611through leaks in the masks due to improper sealing
or from the patient’s mouth. The study by Schwartz
et al.9 supports this hypothesis. These authors
demonstrated that the conditions which create
greater flow through the circuit provide a lower
oxygen concentration to the patient. They propose
that leaks are one of the factors that determine the
final FiO2 administered to the patient during NIV
use. Schwartz quantified these leaks through
various expiratory ports. Those ports that produced
greater leakage (such as the ‘‘exhaust vent masks’’)
generated lower FiO2. The above authors did not
evaluate the involvement of the ‘‘unintended
leakage’’ onto the FiO2. They supposed that this
unintended leakage could reduce the FiO2. Thys et
al.10 compared the FiO2 obtained with different
IPAP levels and concluded that using low oxygen
flow, FiO2 increased parallelly with the increase in
IPAP up to 12 cmH2O [1.173 kPa] but a greater
increase in IPAP only produced a reduction in thepatient’s oxygen delivery. If a greater oxygen flow
is used, FiO2 decreases proportionally with the IPAP
increase. These results confirm the previous idea of
the ‘‘dilutory effect’’ generated by high airflow as a
consequence of the increase of volume minute
ventilation generated by NIPPV.
EPAP changes also modify the FiO2. Increases in
EPAP could generate greater oxygen leakage
through the expiratory port. This would lead to a
decrease in the mask oxygen concentration, reach-
ing a lower FiO2. This concept is supported by
Waugh et al.,11 who, maintaining a stable IPAP/
EPAP relation, showed that EPAP modifications
cause a fall in FiO2. In our report, the use of a
fixed IPAP/EPAP relation did not allow us to reach a
conclusion on this point. The reduced FiO2 with
greater levels of EPAP is another expression of the
‘‘dilution oxygen explanation’’ (the ‘‘mix effect’’).
The relation between FiO2 and oxygen connec-
tion point modifications could be explained at least
in part by a certain amount of logic. Oxygen
delivered directly to the mask generates greater
FiO2 as this system reduces the ‘‘mix effect’’ with
circuit air, as occurs when the oxygen is adminis-
tered directly to the tube circuit. Our results
coincide with those of Schwartz et al.9 These
authors argue that FiO2 could be greater using the
mask connection point as long as the expiratory
device is situated in the tube circuit, as with our
system. If O2 is administered directly to a mask
with a leak port, O2 may be lost due to the
proximity of these two ports. In this situation, the
FiO2 would decrease.
Thys et al.10 found a different result. They
obtained a higher FiO2 by connecting the oxygen
into the circuit just before the expiratory port and
suggested that the oxygen mix is more homoge-
neous when it is administered at this point. If the
connection point was located nearer the patient,
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reduce the FiO2 delivered. Besides, while using this
connection point, the oxygen delivered during
expiration would be eliminated through the ex-
piratory port and would not therefore reach the
patient. Although this was not evaluated, oxygen
administration immediately before the expiratory
device would create an oxygen-rich store for
inhalation at the next respiratory cycle. It is
difficult to interpret the diversity between Thys
et al.’s and our findings. The use of an experimental
lung model without the dynamics of a real lung,
distinct location of measurements of FiO2 and low
oxygen flow could explain these differences.
Waugh et al.’11s results also differed consider-
ably from our findings. They showed that the
oxygen connection point located nearest to the
ventilator generated greater FiO2 than the mask
connection. Like Thys et al.,10 they proposed that
the ventilator system acts as an oxygen reservoir;
the closer the oxygen connection to the ventilator,
the greater the oxygen load to the patient.
However, we must take into account that just as
the system could become an oxygen reservoir, it
could also allow a greater loss of oxygen through
the expiratory port during the expiratory phase of
the ventilation cycle, thereby reducing FiO2.
Lastly, measuring FiO2 through a sensor inserted
into the trachea through a tracheostomy tube,
Padkin and Kinnear12 found no significant differ-
ences in FiO2 using different connection points.
They showed that even though the patient receives
a similar quantity of total oxygen with both
connection points, the point-to-point gas concen-
tration differs during ventilatory cycle. They
suggest that there could be a distinct mix of the
oxygen with air from the anatomical dead volume
and that corresponding to the mask and the circuit.
When oxygen was supplied via the ventilator
tubing, the patients initially received anatomical
dead space gas followed by mask gas during
inspiration. Tracheal oxygen concentration initially
remained close to that of the end-expired gas and
then rose to a maximum at end-inspiration. This
was due to gas from the ventilator tubing, which
acted as an oxygen reservoir during previous
expiration. In this way, mFiO2 was reached at
end-inspiration. When oxygen was supplied via the
nasal mask, the patient initially received gas with a
FiO2 concentration close to the end-expiratory
oxygen concentration. This gas came from the
anatomical dead space. Thereafter, the patient
received gas from the nasal mask that had been
enriched with oxygen during the previous expira-
tory phase and end-expiratory pause. Unlike the
previous system, mFiO2 was achieved in mid-inspiration. This report used only 0–6 L/min of
oxygen flow. The finding of significant differences in
FiO2 consequent to oxygen flow variations could
perhaps be observed with greater flows, like those
used in other reports.9–11
In the present study, the greatest MV was
obtained with BiPAP mode. This was concordant
with the increase in tidal and MV generated by
positive pressure ventilation as one of its mechan-
isms of action.4 CPAP does not have a true
ventilatory effect and the MV reached with this
system was consequently lower. In contrast with
our report, Thys et al.10 concluded that neither
tidal volume nor respiratory frequency actively
participated as FiO2 determinants. However, we
must take into account that this work was
performed with an experimental lung model which
could explain the differences with the ‘‘in vivo’’
results in our report. To our knowledge, no other
studies to date analyse the impact of ventila-
tory MV on the final FiO2 administered to the
patient during ventilatory support. Once again, the
‘‘mix effect’’ could explain the inverse relation of
MV and FiO2.
There are several limitations in our study. Firstly,
this work was performed in healthy volunteers.
Evaluation of patients with acute and chronic
ventilatory failure would perhaps show other
variables that could modify the FiO2. In this
scenario, a lower MV and consequently a greater
FiO2 could be achieved than those reached in our
work. Second, the use of prefixed pressures
(IPAP–EPAP–CPAP) and oxygen flow (15 L/min) does
not allow us to show the FiO2 differences obtained
with other ventilation parameters.
Finally, with the ‘‘open ventilatory system’’ and
the artefact in MV measurement generated by the
external addition of oxygen, we were unable to
measure the exact MV delivered to the patient.
This factor explains the differences in MV while
using the same ventilatory mode with the different
oxygen connection points.
In patients with severe hypoxaemic respiratory
failure, the FiO2 achieved with a portable venti-
lator could be insufficient. In this scenario, CPAP
and distal connection of oxygen is the mode of
ventilatory support that achieves the highest
mFiO2. The use of BiPAP mode with portable
ventilators could not generate sufficient FiO2 to
treat these patients. Nevertheless, portable venti-
lators were able to achieve sufficient FiO2 to treat
patients without greater oxygen demands such as
COPD exacerbations.
In conclusion, we can state that the FiO2
achieved during NIPPV with a portable ventila-
tor was influenced by three main factors: the
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the MV generated. These aspects must be kept in
mind when treating severe hypoxemic patients with
these ventilators.Acknowledgements
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